IL149197A0 - Process for preparing oxazolines from tetrahydrofurans - Google Patents

Process for preparing oxazolines from tetrahydrofurans

Info

Publication number
IL149197A0
IL149197A0 IL14919700A IL14919700A IL149197A0 IL 149197 A0 IL149197 A0 IL 149197A0 IL 14919700 A IL14919700 A IL 14919700A IL 14919700 A IL14919700 A IL 14919700A IL 149197 A0 IL149197 A0 IL 149197A0
Authority
IL
Israel
Prior art keywords
preparation
tetrahydrofurans
oxazolines
disclosed
nelfinavir
Prior art date
Application number
IL14919700A
Other languages
English (en)
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of IL149197A0 publication Critical patent/IL149197A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL14919700A 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans IL149197A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16069599P 1999-10-21 1999-10-21
PCT/US2000/028815 WO2001029013A1 (fr) 1999-10-21 2000-10-19 Procedes destines a la preparation d'oxazolines a partir de tetrahydrofurannes

Publications (1)

Publication Number Publication Date
IL149197A0 true IL149197A0 (en) 2002-11-10

Family

ID=22578030

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14919700A IL149197A0 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans

Country Status (21)

Country Link
US (3) US6403799B1 (fr)
EP (1) EP1224177B1 (fr)
JP (2) JP2003512361A (fr)
KR (1) KR100706938B1 (fr)
CN (3) CN1539834A (fr)
AT (1) ATE259360T1 (fr)
AU (1) AU775783B2 (fr)
BR (1) BR0015229A (fr)
CA (1) CA2387997C (fr)
CZ (1) CZ20021361A3 (fr)
DE (1) DE60008270T2 (fr)
DK (1) DK1224177T3 (fr)
ES (1) ES2215737T3 (fr)
HK (2) HK1051365A1 (fr)
HU (1) HUP0203214A3 (fr)
IL (1) IL149197A0 (fr)
PL (1) PL364878A1 (fr)
PT (1) PT1224177E (fr)
RU (1) RU2242468C2 (fr)
SI (1) SI1224177T1 (fr)
WO (1) WO2001029013A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014011900A2 (fr) 2012-07-11 2014-01-16 Blueprint Medicines Inhibiteurs du récepteur du facteur de croissance de fibroblastes
EP3060560A1 (fr) 2013-10-25 2016-08-31 Blueprint Medicines Corporation Inhibiteurs du récepteur du facteur de croissance des fibroblastes
WO2015108992A1 (fr) 2014-01-15 2015-07-23 Blueprint Medicines Corporation Composés hétérobicycliques et leur utilisation en tant qu'inhibiteurs du récepteur fgfr4

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
AU6087194A (en) 1993-01-15 1994-08-15 Agouron Pharmaceuticals, Inc. Hiv protease inhibitors
TW270118B (fr) 1993-02-26 1996-02-11 Schering Corp
US5527829A (en) 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
EP0983999B8 (fr) 1995-09-26 2005-06-08 Japan Tobacco Inc. Procede de production de derives amides et de leurs intermediaires
EP0984000B1 (fr) 1995-09-26 2008-12-03 Japan Tabacco Inc. Procede de production de derives amides et de leurs intermediaires
US5925759A (en) * 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5962725A (en) * 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
SI1224177T1 (en) 2004-06-30
CN1162408C (zh) 2004-08-18
CN1539832A (zh) 2004-10-27
HUP0203214A2 (hu) 2003-01-28
EP1224177B1 (fr) 2004-02-11
ATE259360T1 (de) 2004-02-15
ES2215737T3 (es) 2004-10-16
DK1224177T3 (da) 2004-05-03
US20030023092A1 (en) 2003-01-30
JP2008007522A (ja) 2008-01-17
US6403799B1 (en) 2002-06-11
US20020038033A1 (en) 2002-03-28
BR0015229A (pt) 2002-07-23
PT1224177E (pt) 2004-06-30
CN1266140C (zh) 2006-07-26
AU8029000A (en) 2001-04-30
KR20020047255A (ko) 2002-06-21
US6472534B2 (en) 2002-10-29
PL364878A1 (en) 2004-12-27
CN1539834A (zh) 2004-10-27
JP2003512361A (ja) 2003-04-02
CN1390210A (zh) 2003-01-08
EP1224177A1 (fr) 2002-07-24
HUP0203214A3 (en) 2005-01-28
CZ20021361A3 (cs) 2003-03-12
DE60008270T2 (de) 2004-07-15
KR100706938B1 (ko) 2007-04-11
AU775783B2 (en) 2004-08-12
DE60008270D1 (de) 2004-03-18
HK1051365A1 (en) 2003-08-01
HK1068880A1 (en) 2005-05-06
RU2242468C2 (ru) 2004-12-20
CA2387997C (fr) 2006-06-13
CA2387997A1 (fr) 2001-04-26
WO2001029013A1 (fr) 2001-04-26

Similar Documents

Publication Publication Date Title
DK0835257T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af camptothecin-derivater (CPT-11) og beslægtede forbindelser
CA2405486A1 (fr) Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
PL358887A1 (en) Process for the preparation of substituted octanoyl amides
IL149846A0 (en) Method for obtaining nucleic acids from an evironment sample, resulting nucleic acids and use in synthesis of novel compounds
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
HK1068880A1 (en) Process for preparing oxazolines from tetrahydroforans
IL195385A0 (en) A process for preparing arylamine derivatives
FI963452A0 (fi) Menetelmä epoxidin valmistamiseksi
YU30202A (sh) Postupak za dobijanje oksazolina iz tetrahidrofurana
BG104243A (en) Method for the synthesis of quinoline derivatives
DK1089976T3 (da) Fremgangsmåde til fremstilling af 5-bromisoquinolin og dets 8-nitroderivat
NO20024503D0 (no) Fremgangsmåte for tilföring av startkulturer med en reproduserbar kvalitet
YU1500A (sh) Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijena jedinjenja i korišćenje ovih jedinjenja
RS20050760A (sr) Postupak za izradu fenilamida 5-(4- fluorofenil)-1-(2-((2r, 4r)-4-hidroksi- 6-okso-tetrahidro-piran-2-il)etil)-2- izopropil-4-fenil-1h-pirol-3- karboksilne kiseline
HRP20020021B1 (en) Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
RU2003132433A (ru) Способ получения 2-[5-(4-фторфенил)-3- пиридилметиламинометил]хромана
Armstrong et al. Aminative rearrangement of 2-alkoxy-3, 4-dihydro-2 H-pyrans: a novel stereocontrolled route to substituted pyrrolidines
IL156078A0 (en) Cyclizing method for synthesis of compounds derived from pyrrolidine
NO20055836L (no) Intermediater anvendelige ved syntesen av HIV-proteaseinhibitorer og fremgangsmater for fremstilling av samme
YU23301A (sh) Postupak za dobijanje supstituisanih piridina
DK1084099T3 (da) Fremgangsmåde til fremstilling af beskyttet 3-amino-1,2-dihydroxypropan-acetal og derivater deraf
DK1268441T3 (da) Mellemprodukt og fremgangsmåde til dets syntese
ZA200203532B (en) Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds.
HUP9800542A2 (hu) Epoxi-azetidinonok, eljárás előállításukra és alkalmazásuk
NO20010122L (no) Fremgangsmåte for stereoselektiv fremstilling av Grignard- forbindelser og anvendelse derav